Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.77 USD
−15.96 M USD
0.00 USD
8.04 M
About Lantern Pharma Inc.
Sector
CEO
Panna L. Sharma
Headquarters
Dallas
Website
Founded
2013
FIGI
BBG00GM6LK17
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LTRN is 3.43 USD — it has increased by 3.34% in the past 24 hours. Watch Lantern Pharma Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lantern Pharma Inc. stocks are traded under the ticker LTRN.
LTRN stock has fallen by −14.63% compared to the previous week, the month change is a 2.89% rise, over the last year Lantern Pharma Inc. has showed a −20.97% decrease.
We've gathered analysts' opinions on Lantern Pharma Inc. future price: according to them, LTRN price has a max estimate of 26.00 USD and a min estimate of 15.00 USD. Watch LTRN chart and read a more detailed Lantern Pharma Inc. stock forecast: see what analysts think of Lantern Pharma Inc. and suggest that you do with its stocks.
LTRN reached its all-time high on Oct 12, 2020 with the price of 24.84 USD, and its all-time low was 2.38 USD and was reached on Nov 1, 2023. View more price dynamics on LTRN chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LTRN stock is 6.15% volatile and has beta coefficient of 2.61. Track Lantern Pharma Inc. stock price on the chart and check out the list of the most volatile stocks — is Lantern Pharma Inc. there?
Today Lantern Pharma Inc. has the market capitalization of 38.39 M, it has increased by 9.71% over the last week.
Yes, you can track Lantern Pharma Inc. financials in yearly and quarterly reports right on TradingView.
Lantern Pharma Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
LTRN earnings for the last quarter are −0.42 USD per share, whereas the estimation was −0.56 USD resulting in a 25.00% surprise. The estimated earnings for the next quarter are −0.51 USD per share. See more details about Lantern Pharma Inc. earnings.
Lantern Pharma Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
LTRN net income for the last quarter is −4.51 M USD, while the quarter before that showed −4.96 M USD of net income which accounts for 9.15% change. Track more Lantern Pharma Inc. financial stats to get the full picture.
No, LTRN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 21.00 employees. See our rating of the largest employees — is Lantern Pharma Inc. on this list?
Like other stocks, LTRN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lantern Pharma Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lantern Pharma Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lantern Pharma Inc. stock shows the sell signal. See more of Lantern Pharma Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.